STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

  1. Home
  2. Sec-filings
  3. IMVT
  4. [ARS] Immunovant, Inc. SEC Filing

[ARS] Immunovant, Inc. SEC Filing

Filing Impact
(No impact)
Filing Sentiment
(Neutral)
Form Type
ARS
ARS - Immunovant, Inc.

ARS Filing - Immunovant, Inc.

This filing is available as a PDF document.

Filing Type: ARS

Company: Immunovant, Inc. (IMVT)

Acceptance Date: 2025-07-09T16:57:33.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Stock IMVT logo
Immunovant Inc

NASDAQ:IMVT

IMVT Rankings

#1537 Ranked by Market Cap
N/A Ranked by Dividends

IMVT Latest News

Dec 11, 2025
Immunovant Announces Pricing of $550 Million Common Stock Financing
Nov 10, 2025
Immunovant Provides Corporate Updates and Reports Financial Results for the Second Quarter Ended September 30, 2025
Oct 27, 2025
Immunovant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025
Sep 3, 2025
Immunovant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves' Disease Patients
Aug 11, 2025
Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter Ended June 30, 2025

IMVT Latest SEC Filings

Nov 21, 2025
[Form 4] Immunovant, Inc. Insider Trading Activity
Nov 21, 2025
[8-K] Immunovant, Inc. Reports Material Event
Nov 10, 2025
[10-Q] Immunovant, Inc. Quarterly Earnings Report
Nov 10, 2025
[8-K] Immunovant, Inc. Reports Material Event
Oct 24, 2025
[Form 4] Immunovant, Inc. Insider Trading Activity

IMVT Stock Data

4.35B
73.92M
57.08%
55.6%
8.93%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
NEW YORK